📄 Extracted Text (316 words)
From: J <jeevacation®gmail.com>
To: Paul Barrett <1
Subject: Re: To Do
Date: Tue, 29 Jan 2019 16:32:44 +0000
Inline-Images: image003.jpg
Ok
On Tue, Jan 29, 2019 at 5:25 PM Paul Barrett <1 > wrote:
Jeffrey
We should take profits on Broadcom. We are up $110,000 on our $2MM position. The semi index is up 15%
from the lows in December. It feels like the short covering rally is over and recent earnings reports from the
likes of Nvidia have been very disappointing which I suspect will put pressure on the whole sector.
I think getting exposure to 5O would be a better use of the proceeds. Testing of 5G equipment will be a huge
market over the coming years. Keysight (KEYS) provides testing for all parts of the 5G network - base
stations, cell sites, equipment, networks etc. Keysight will benefit across the spectrum for the next 2 years and
has #1 market share across the globe and is the scale beneficiary.
Ticker: KEYS
Market Cap: $13b1n
2019 PIE: 19x
Only 6 analysts cover the stock so it is under the radar which I like. This is a top pick from the research shop I
like out of London (who gave us CD Projekt).
Paul
Paul Barrett
Alpha Group Capital LLC
EFTA01028317
142 W 57th Street, 11t h Floor, New York, NY 10019
646-876-5277 (o) 646-342-6930 (c)
please note
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
JEE
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA01028318
ℹ️ Document Details
SHA-256
9f198046d965172944fe42038c8d1645a23cc3d1f5f15eea54bbbac5d4cb9981
Bates Number
EFTA01028317
Dataset
DataSet-9
Document Type
document
Pages
2
Comments 0